Known as the VITAL study–VITamin D and OmegA-3 TriaL (VITAL) held at Brigham and Women’s Hospital, an affiliate of Harvard Medical School, in Boston, Massachusetts. VITAL was an ongoing research study in 25,871 men and women across the U.S. investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk for developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. According to recent news in NPR, the results were disappointing. See the link for more information.
Lead Research/InvestigatorSource: NPR